HPV vaccine: Key questions answered as cervical cancer deaths fall to zero in women under 24
A new study indicates that HPV vaccination in early adolescence has reduced cervical cancer deaths to zero in women aged 20-24 in England. Health officials emphasize that while the vaccine is highly effective, regular screenings remain essential for comprehensive protection.
Why it matters
This data demonstrates the long-term public health success of national vaccination programs in eradicating preventable cancer mortality.
As our coverage draws to a close, here s a recap on what you need to know about HPV (human papillomavirus):
The article reports on public health statistics and medical guidance without political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in